TLACPH Consulting ApS: Financial statements 2025
CVR: 40250360
Source: annual report 2025, Danish Business Authority
01/04/2024 – 31/03/2025
TLACPH Consulting ApS (CVR 40250360) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 35,979 and a net result of DKK 34,074 compared with DKK 53,389 the year before. That is a decrease of 43.3% compared with the year before. Equity in the 2025 report amounted to DKK 151,566. The solvency ratio was 55%.
- Gross Profit
- DKK 35,979
- Profit/Loss
- DKK 34,074
- Equity
- DKK 151,566
- Total Assets
- DKK 275,638
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 36 t. | 34 t. | 152 t. | - |
| 2024 | 78 t. | 63 t. | 53 t. | 167 t. | 0 |
| 2023 | - | 176 t. | 226 t. | 314 t. | - |
| 2022 | - | 950 t. | 890 t. | 2.5 mio. | - |
| 2021 | - | 2 mio. | 1.6 mio. | 1.6 mio. | - |
Official annual report
How creditworthy is TLACPH Consulting ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout TLACPH Consulting ApS
TLACPH Consulting ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named TLACPH Consulting IVS and Norse Therapeutics IVS. The management consists of Thomas Lars Andresen. The company is owned by TLA-HOLDING 2010 ApS. According to the 2024 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 35,979 and a net result of DKK 34,074 compared with DKK 53,389 the year before. Equity in the 2025 report amounted to DKK 151,566.